Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from ELV

The stock market is expected to remain volatile in the near term as investors remain anxious about the Fed’s actions. Amid high recession worries, fundamentally strong healthcare stocks, Pfizer (PFE), Bristol-Myers Squibb (BMY), Amgen (AMGN), and Elevance Health (ELV), which have the potential to withstand any market downturns, could be…

StockNews.com

3 Stocks to Help Protect Your Portfolio Through 2023

With the Fed likely to go ahead with its interest rate hikes this year, the market will likely remain under pressure. Given the foreseen volatility in the stock market, investors might consider investing in stable and dividend-paying stocks Merck & Co. (MRK), Elevance Health (ELV), and Waste Management (WM) to…

StockNews.com

The 3 Best Long-Term Stocks to Buy Now

Amid the Fed’s hawkish stance to keep raising interest rates in 2023 and weakening economic outlook, a recession looks imminent next year. Amid ongoing market uncertainties, investors should focus on their long-term strategies. Therefore, fundamentally sound dividend-paying stocks, Coca-Cola Company (KO), Elevance Health (ELV), and Weis Markets (WMK) could be…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 No-Brainer Stocks to Buy Now for the Long Term

Despite widespread macro headwinds, the U.S. economy and its tight labor market look resilient enough to sustain possible downturns in the upcoming term. Moreover, as the stock market is expected to make a comeback soon, Comcast (CMCSA), Elevance Health (ELV), and Waste Management (WM) could be no-brainer stocks to buy…

StockNews.com

The 4 Best Stocks to Buy Amid Market Volatility

Markets will likely remain extremely volatile ahead of the November Consumer Price Index (CPI) report and the Fed’s December policy decisions. Overall, the odds of the economy sliding into a recession are increasing. Given the uncertain economic backdrop, we think it could be wise to invest in fundamentally strong stocks…

StockNews.com

4 Stocks You'll Regret Not Buying on the Dip

Due to the macroeconomic and geopolitical concerns, many fundamentally strong stocks are trading much below their 52-week highs. With inflation easing and the Fed hinting at a slowdown in the pace of rate increases, investors could look to capitalize on the positive sentiment by buying fundamentally strong stocks, Lockheed Martin…

StockNews.com

2 Stocks That Are Too Good of Buying Opportunities to Ignore

The latest CPI report shows signs of a cooling down inflation. On the other hand, the healthcare market is expected to boom amid increasing health awareness and technological advancements. Hence, we think fundamentally robust healthcare stocks Merck & Co. (MRK) and Elevance Health (ELV) could be solid investments now. Read…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Stocks You Don't Want to Overlook During a Choppy Market

With another significant interest rate hike putting further pressure on the compressed margins of most companies and enhancing the odds of a recession, the market is unlikely to stabilize anytime soon. Amid an uncertain market backdrop, loading up on fundamentally strong stocks Coca-Cola (KO), Elevance Health (ELV), and Casey’s General…

StockNews.com

3 Stocks to Buy With Rising Recession and Rate Risk

The stock market continues to be a challenging environment with rising rates a potent headwind. So far, the economy has been stable enough so that earnings growth has not contracted, but this is unlikely to persist the longer the Fed stays hawkish. This article discusses characteristics of stocks that are…

StockNews.com

2 Defensive Stocks to Consider With Market Conditions Turning More Bearish

The stock market has given back the bulk of its gains following a stronger than expected inflation print. Amid these challenging circumstances, investors should consider high-quality, defensive stocks like Elevance Health (ELV) and Northrop Grumman (NOC).

StockNews.com

This Is What Whales Are Betting On Elevance Health

Someone with a lot of money to spend has taken a bullish stance on Elevance Health (NYSE:ELV). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Despite Pullback, these 3 Stocks Are Still Trading Above Their Moving Averages

Despite the market’s massive decline since the beginning of the year on concerns over macroeconomic and geopolitical issues, Elevance Health (ELV), Waste Management (WM), and Coca-Cola FEMSA (KOF) continued to soar and are currently trading above their moving averages. Since these stocks are expected to maintain their momentum based on…

StockNews.com

3 Worry-Free Health Care Stocks to Invest in Right Now

Amid the ongoing economic turbulence, sectors like healthcare, which enjoy inelastic demand and can pass on an increase in cost to end consumers, make a good investment option. Moreover, rising chronic diseases, an aging population, and increased healthcare spending should drive the sector’s growth. So, it could be the right…

StockNews.com

Is This "Strong Buy" Health Insurance Company a Bargain?

Healthcare company Elevance Health (ELV) reported solid revenue growth in the last reported quarter. While the stock trades at a discount to its peers, analysts expect the company’s financials to improve. So, let’s evaluate if it would be wise to buy the stock now. Read on.

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Is This "Strong Buy" Health Insurance Company A Bargain?

Benzinga

Here's How Much You Would Have Made Owning Elevance Health Stock In The Last 10 Years

Elevance Health (NYSE:ELV) has outperformed the market over the past 10 years by 12.12% on an annualized basis producing an average annual return of 22.8%. Currently, Elevance Health has a market capitalization of $115.15 billion.

1 2 3

People

Jerome Powell

3,227 stories

Mangeet Kaur BounsMangeet

Jaimini DesaiJaimini Desai

59 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.